The present invention provides methods, kits, and pharmaceutical
compositions for limiting scar or adhesion formation by administration of
angiotensinogen, AI, AI analogues, and/or AI fragments and analogues
thereof, AII analogues, AII fragments or analogues thereof, ACE
inhibitors, AII AT.sub.2 type 2 receptor agonists, either alone or in
combination with other compounds.
De onderhavige uitvinding verstrekt methodes, uitrustingen, en farmaceutische samenstellingen voor het beperken van litteken of adhesievorming door beleid van angiotensinogen, AI, AI analogons, en/of AI fragmenten en analogons daarvan, analogons AII, fragmenten AII of analogons daarvan, ACE inhibitors, AII AT.sub.2 type 2 receptoragonists, of alleen of in combinatie met andere samenstellingen.
